The Asia Pacific Organ-on-Chip Market would witness market growth of 31.2% CAGR during the forecast period (2022-2028).
A lab-on-a-chip is a device that combines one or more laboratory operations onto a single chip that handles particles in microfluidic channels. It has been created for more than a decade. Advantages of handling particles on such a small scale include decreased fluid volume utilization (lower reagents costs and less waste), increased mobility of the devices, more process control (owing to faster thermo-chemical reactions), and lower fabrication costs. Moreover, microfluidic flow is completely laminar (i.e., no turbulence).
Consequently, there is minimal mixing between adjacent streams within a single hollow channel. In the field of cellular biology convergence, this uncommon property of fluids has been utilized to study complex cell behaviors, such as cell motility in response to stem cell differentiation, chemotactic stimuli, axon guidance, subcellular propagation of biochemical signaling, and embryonic development.
3D cell-culture models outperform 2D culture systems by fostering greater cell differentiation as well as tissue organization. 3D culture systems are more effective because the flexibility of the ECM gels enables shape variations and cell-cell interactions – traditionally restricted by stiff 2D culture substrates. In spite of this, even the best 3D culture models fail to mimic an organ's cellular properties in many respects, such as tissue-to-tissue interfaces (e.g. epithelium as well as vascular endothelium), spatiotemporal gradients of chemical compounds, and the mechanically active microenvironments.
The Make in India effort of the Indian government is encouraging domestic production of medical devices and lowering patient costs for formerly imported products, such as stents and implants. In India, the legislative environment and regulators must also allow technological interventions, such as the expansion of online pharmacies, with the necessary regulations. Due to the increasing advancements and expanding adoption of novel technologies, the demand for organ-on-chip would also increase. This factor is expediting the growth of the regional market.
The China market dominated the Asia Pacific Organ-on-Chip Market by Country in 2021; thereby, achieving a market value of $56,436.4 Thousands by 2028. The Japan market is registering a CAGR of 30.4% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 32% during (2022 - 2028).
Based on Type, the market is segmented into Lung on chip, Heart on chip, Human on chip, Kidney on chip, Liver on chip, and Intestine on chip. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Organ-on-Chip Market is Projected to reach USD 815.6 Million by 2028, at a CAGR of 30.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AxoSim, Inc., Visikol, Inc., CN Bio Innovations Limited., Elveflow (Elvesys Group), Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc. and TARA Biosystems, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Lung on chip
- Heart on chip
- Human on chip
- Kidney on chip
- Liver on chip
- Intestine on chip
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- AxoSim, Inc.
- Visikol, Inc.
- CN Bio Innovations Limited.
- Elveflow (Elvesys Group)
- Emulate, Inc.
- Insphero AG,
- Mimetas B.V.
- Nortis Inc.
- Organovo Holdings, Inc.
- TARA Biosystems, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Organ-on-Chip Market, by Type
1.4.2 Asia Pacific Organ-on-Chip Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Organ-on-Chip Market by Type
3.1 Asia Pacific Lung on chip Market by Country
3.2 Asia Pacific Heart on chip Market by Country
3.3 Asia Pacific Human on chip Market by Country
3.4 Asia Pacific Kidney on chip Market by Country
3.5 Asia Pacific Liver on chip Market by Country
3.6 Asia Pacific Intestine on chip Market by Country
Chapter 4. Asia Pacific Organ-on-Chip Market by Country
4.1 China Organ-on-Chip Market
4.1.1 China Organ-on-Chip Market by Type
4.2 Japan Organ-on-Chip Market
4.2.1 Japan Organ-on-Chip Market by Type
4.3 India Organ-on-Chip Market
4.3.1 India Organ-on-Chip Market by Type
4.4 South Korea Organ-on-Chip Market
4.4.1 South Korea Organ-on-Chip Market by Type
4.5 Singapore Organ-on-Chip Market
4.5.1 Singapore Organ-on-Chip Market by Type
4.6 Malaysia Organ-on-Chip Market
4.6.1 Malaysia Organ-on-Chip Market by Type
4.7 Rest of Asia Pacific Organ-on-Chip Market
4.7.1 Rest of Asia Pacific Organ-on-Chip Market by Type
Chapter 5. Company Profiles
5.1 Visikol, Inc.
5.1.1 Company Overview
5.2 CN Bio Innovations Ltd.
5.2.1 Company Overview
5.2.2 Recent strategies and developments:
5.2.2.1 Product Launches and Product Expansions:
5.2.2.2 Geographical Expansions:
5.3 Elveflow (Elvesys Group)
5.3.1 Company Overview
5.4 Emulate, Inc.
5.4.1 Company Overview
5.4.2 Recent strategies and developments:
5.4.2.1 Product Launches and Product Expansions:
5.5 Insphero AG
5.5.1 Company Overview
5.6 Mimetas B.V.
5.6.1 Company Overview
5.6.2 Recent strategies and developments:
5.6.2.1 Partnerships, Collaborations, and Agreements:
5.6.2.2 Product Launches and Product Expansions:
5.7 Nortis Inc.
5.7.1 Company Overview
5.8 Organovo Holdings, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Research & Development Expenses
5.9 TARA Biosystems, Inc.
5.9.1 Company Overview
5.10. AxoSim, Inc.
5.10.1 Company Overview
TABLE 1 Asia Pacific Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 2 Asia Pacific Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 3 Asia Pacific Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 4 Asia Pacific Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 5 Asia Pacific Lung on chip Market by Country, 2018 - 2021, USD Thousands
TABLE 6 Asia Pacific Lung on chip Market by Country, 2022 - 2028, USD Thousands
TABLE 7 Asia Pacific Heart on chip Market by Country, 2018 - 2021, USD Thousands
TABLE 8 Asia Pacific Heart on chip Market by Country, 2022 - 2028, USD Thousands
TABLE 9 Asia Pacific Human on chip Market by Country, 2018 - 2021, USD Thousands
TABLE 10 Asia Pacific Human on chip Market by Country, 2022 - 2028, USD Thousands
TABLE 11 Asia Pacific Kidney on chip Market by Country, 2018 - 2021, USD Thousands
TABLE 12 Asia Pacific Kidney on chip Market by Country, 2022 - 2028, USD Thousands
TABLE 13 Asia Pacific Liver on chip Market by Country, 2018 - 2021, USD Thousands
TABLE 14 Asia Pacific Liver on chip Market by Country, 2022 - 2028, USD Thousands
TABLE 15 Asia Pacific Intestine on chip Market by Country, 2018 - 2021, USD Thousands
TABLE 16 Asia Pacific Intestine on chip Market by Country, 2022 - 2028, USD Thousands
TABLE 17 Asia Pacific Organ-on-Chip Market by Country, 2018 - 2021, USD Thousands
TABLE 18 Asia Pacific Organ-on-Chip Market by Country, 2022 - 2028, USD Thousands
TABLE 19 China Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 20 China Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 21 China Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 22 China Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 23 Japan Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 24 Japan Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 25 Japan Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 26 Japan Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 27 India Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 28 India Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 29 India Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 30 India Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 31 South Korea Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 32 South Korea Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 33 South Korea Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 34 South Korea Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 35 Singapore Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 36 Singapore Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 37 Singapore Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 38 Singapore Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 39 Malaysia Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 40 Malaysia Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 41 Malaysia Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 42 Malaysia Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 43 Rest of Asia Pacific Organ-on-Chip Market, 2018 - 2021, USD Thousands
TABLE 44 Rest of Asia Pacific Organ-on-Chip Market, 2022 - 2028, USD Thousands
TABLE 45 Rest of Asia Pacific Organ-on-Chip Market by Type, 2018 - 2021, USD Thousands
TABLE 46 Rest of Asia Pacific Organ-on-Chip Market by Type, 2022 - 2028, USD Thousands
TABLE 47 Key Information – Visikol, Inc.
TABLE 48 Key Information – CN Bio Innovations Ltd.
TABLE 49 Key Information – Elveflow
TABLE 50 Key Information – Emulate, Inc.
TABLE 51 Key Information – Insphero AG
TABLE 52 Key Information – Mimetas B.V.
TABLE 53 Key Information – Nortis Inc.
TABLE 54 Key Information – Organovo Holdings, Inc.
TABLE 55 Key Information – TARA Biosystems, Inc.
TABLE 56 Key Information – AxoSim, Inc.
List of Figures
FIG 1 Methodology for the research